Division of Biomedical Engineering, School of Engineering, University of Glasgow, Glasgow G12 8LT, UK.
Center for Cell Engineering, Institute of Molecular Cell and Systems Biology, University of Glasgow, Joseph Black Building, University Avenue, Glasgow G12 8QQ, UK.
Sci Adv. 2016 Aug 26;2(8):e1600188. doi: 10.1126/sciadv.1600188. eCollection 2016 Aug.
Growth factors (GFs) are powerful signaling molecules with the potential to drive regenerative strategies, including bone repair and vascularization. However, GFs are typically delivered in soluble format at supraphysiological doses because of rapid clearance and limited therapeutic impact. These high doses have serious side effects and are expensive. Although it is well established that GF interactions with extracellular matrix proteins such as fibronectin control GF presentation and activity, a translation-ready approach to unlocking GF potential has not been realized. We demonstrate a simple, robust, and controlled material-based approach to enhance the activity of GFs during tissue healing. The underlying mechanism is based on spontaneous fibrillar organization of fibronectin driven by adsorption onto the polymer poly(ethyl acrylate). Fibrillar fibronectin on this polymer, but not a globular conformation obtained on control polymers, promotes synergistic presentation of integrin-binding sites and bound bone morphogenetic protein 2 (BMP-2), which enhances mesenchymal stem cell osteogenesis in vitro and drives full regeneration of a nonhealing bone defect in vivo at low GF concentrations. This simple and translatable technology could unlock the full regenerative potential of GF therapies while improving safety and cost-effectiveness.
生长因子(GFs)是具有驱动再生策略潜力的强大信号分子,包括骨修复和血管生成。然而,由于快速清除和有限的治疗效果,GFs 通常以超生理剂量的可溶性形式递送。这些高剂量有严重的副作用且昂贵。尽管已经证实 GF 与细胞外基质蛋白(如纤维连接蛋白)的相互作用控制 GF 的呈现和活性,但尚未实现一种可转化的方法来释放 GF 的潜力。我们展示了一种简单、稳健且受控的基于材料的方法,可在组织愈合过程中增强 GF 的活性。其潜在机制基于纤维连接蛋白通过吸附到聚合物聚(丙烯酸乙酯)上而自发形成纤维状结构。该聚合物上的纤维状纤维连接蛋白(而非在对照聚合物上获得的球状构象)促进了整联蛋白结合位点和结合的骨形态发生蛋白 2(BMP-2)的协同呈现,从而增强了间充质干细胞的体外成骨作用,并在低 GF 浓度下驱动不可愈合的骨缺损的完全再生。这种简单且可转化的技术可以在提高安全性和成本效益的同时,释放 GF 治疗的全部再生潜力。